3 companies won 3 federal contract awards worth $859,764 for in-vitro diagnostic substance manufacturing (NAICS 325413) in New Jersey in our record between April 2026 and October 2026. The largest are Ortho-Clinical Diagnostics, Inc, Roche Diagnostics Corporation, Biomerieux Inc.
3
companies
3
contract awards
$859,764
obligated
| # | Company | UEI | Awards | Obligated | Latest award |
|---|---|---|---|---|---|
| 1 | Ortho-Clinical Diagnostics, Inc | JG5JF2JQJ121 | 1 | $326,624 | 2026-06-29 |
| 2 | Roche Diagnostics Corporation | JDMDFEZBYH36 | 1 | $280,841 | 2026-04-16 |
| 3 | Biomerieux Inc | HCNVCMEG9NL6 | 1 | $252,300 | 2026-10-19 |
| Company | Agency | Obligated | Signed | Record |
|---|---|---|---|---|
| Biomerieux Inc | Department of Veterans Affairs | $252,300 | 2026-10-19 | 36C24227N0054 on USAspending.gov (opens in a new tab) |
| Ortho-Clinical Diagnostics, Inc | Department of Veterans Affairs | $326,624 | 2026-06-29 | 36C24226N0602 on USAspending.gov (opens in a new tab) |
| Roche Diagnostics Corporation | Department of Veterans Affairs | $280,841 | 2026-04-16 | 36C24226N0470 on USAspending.gov (opens in a new tab) |
From USAspending.gov. Award totals are federal obligations, not company revenue.